ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2024, 'Authors' Reply: Dialysate Sodium and Mortality: One Size Does Not Fit All.', J Am Soc Nephrol, 35, pp. 977, http://dx.doi.org/10.1681/ASN.0000000000000405
,2024, '#1657 Impact of cumulative fluid and sodium imbalance exposure on cause-specific mortality in hemodialysis', Nephrology Dialysis Transplantation, 39, http://dx.doi.org/10.1093/ndt/gfae069.808
,2024, 'Climate Change, Kidney Health, and Environmentally Sustainable Kidney Care: A Multinational Survey of Health Care Professionals.', J Am Soc Nephrol, http://dx.doi.org/10.1681/ASN.0000000000000402
,2024, 'Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)', Kidney International Supplements, 13, pp. 110 - 122, http://dx.doi.org/10.1016/j.kisu.2024.01.004
,2024, 'Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients', Value in Health, 27, pp. 469 - 477, http://dx.doi.org/10.1016/j.jval.2024.01.011
,2024, 'The Association of Frailty and Malnutrition With Dietary Intake and Gastrointestinal Symptoms in People With Kidney Failure: 2-Year Prospective Study', Journal of Renal Nutrition, 34, pp. 177 - 184, http://dx.doi.org/10.1053/j.jrn.2023.10.006
,2024, 'Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team', Journal of the American Society of Nephrology, 35, pp. 229 - 231, http://dx.doi.org/10.1681/ASN.0000000000000289
,2024, 'Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort', Journal of the American Society of Nephrology, 35, pp. 167 - 176, http://dx.doi.org/10.1681/ASN.0000000000000262
,2024, 'A Multinational, Multicenter Study Mapping Models of Kidney Supportive Care Practice', Kidney International Reports, http://dx.doi.org/10.1016/j.ekir.2024.04.055
,2024, 'Conservative kidney management and kidney supportive care: core components of integrated care for people with kidney failure', Kidney International, 105, pp. 35 - 45, http://dx.doi.org/10.1016/j.kint.2023.10.001
,2024, 'Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial', Diabetes, Obesity and Metabolism, http://dx.doi.org/10.1111/dom.15685
,2024, 'Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research', Canadian Journal of Kidney Health and Disease, 11, http://dx.doi.org/10.1177/20543581231217857
,2024, 'WCN24-1230 ASSESSING THE CURRENT EVIDENCE ON ENVIRONMENTALLY SUSTAINABLE KIDNEY CARE: A SCOPING REVIEW BY THE ISN EMERGING LEADERS PROGRAM COHORT 2022-2023', Kidney International Reports, 9, pp. S264 - S264, http://dx.doi.org/10.1016/j.ekir.2024.02.542
,2024, 'WCN24-1278 Climate change, kidney care, and sustainability: A KAP survey of health professionals', Kidney International Reports, 9, pp. S265 - S265, http://dx.doi.org/10.1016/j.ekir.2024.02.544
,2024, 'WCN24-956 CULTIVATING ECO-CONSCIOUS KIDNEY CARE: INTRODUCTION OF THE ISN EMERGING LEADERS PROGRAM ENVIRONMENTALLY SUSTAINABLE KIDNEY CARE TOOLKIT', Kidney International Reports, 9, pp. S636 - S636, http://dx.doi.org/10.1016/j.ekir.2024.02.1342
,2023, 'Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial', BMC Nephrology, 24, http://dx.doi.org/10.1186/s12882-023-03399-5
,2023, 'Sex differences in pain expressed by patients across diverse disease states: individual patient data meta-analysis of 33,957 participants in 10 randomized controlled trials', Pain, 164, pp. 1666 - 1676, http://dx.doi.org/10.1097/j.pain.0000000000002884
,2023, 'The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials', Diabetes, Obesity and Metabolism, 25, pp. 2151 - 2162, http://dx.doi.org/10.1111/dom.15091
,2023, 'Green nephrology: a series of mini reviews on minimizing the environmental impact of kidney health care', Kidney International, 104, pp. 7 - 11, http://dx.doi.org/10.1016/j.kint.2023.03.038
,2023, 'Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial', American Journal of Kidney Diseases, 82, pp. 84 - 96.e1, http://dx.doi.org/10.1053/j.ajkd.2022.12.015
,2023, 'Climate Change, Heat-Related Acute Kidney Disease, and the Need for Action', American Journal of Kidney Diseases, 81, pp. 501 - 503, http://dx.doi.org/10.1053/j.ajkd.2022.11.002
,2023, 'Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study', American Journal of Kidney Diseases, 81, pp. 575 - 582.e1, http://dx.doi.org/10.1053/j.ajkd.2022.10.015
,2023, 'Carbon emissions and hospital pathology stewardship: a retrospective cohort analysis', Internal Medicine Journal, 53, pp. 584 - 589, http://dx.doi.org/10.1111/imj.15622
,2023, 'Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu', Kidney International, 103, pp. 6 - 12, http://dx.doi.org/10.1016/j.kint.2022.10.013
,2023, 'Comparing survival in patients with chronic kidney disease across three countries – Results from the study of heart and renal protection-extended review', Nephrology, 28, pp. 36 - 43, http://dx.doi.org/10.1111/nep.14127
,2023, 'Assessing the Current Evidence on Environmental Sustainability in Nephrology: Protocol for a Scoping Review by the International Society of Nephrology, Emerging Leaders Program Cohort 2022-2024', Journal of the American Society of Nephrology, 34, pp. 1096 - 1097, http://dx.doi.org/10.1681/asn.20233411s11096c
,2023, 'Mesangial Proliferative Glomerulonephritis and Neurocysticercosis: A Novel Association', Journal of the American Society of Nephrology, 34, pp. 602 - 602, http://dx.doi.org/10.1681/asn.20233411s1602b
,2023, 'The Impact of Chronic Fluid Overload, Water Imbalance (Tonicity), and Sodium Toxicity on Mortality of Hemodialysis Patients', Journal of the American Society of Nephrology, 34, pp. 875 - 875, http://dx.doi.org/10.1681/asn.20233411s1875a
,2023, 'WCN23-0481 Variation in Symptom Management Approaches in Advanced Kidney Disease', Kidney International Reports, 8, pp. S371 - S372, http://dx.doi.org/10.1016/j.ekir.2023.02.840
,2023, 'WCN23-0764 KIDNEY SUPPORTIVE CARE: A SURVEY OF ACTIVITY AND PRACTICE PATTERNS ACROSS AUSTRALIA, NEW ZEALAND AND THE UNITED KINGDOM', Kidney International Reports, 8, pp. S373 - S374, http://dx.doi.org/10.1016/j.ekir.2023.02.842
,2022, 'The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06355-0
,2022, 'The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial', Diabetes and Metabolism, 48, pp. 101331, http://dx.doi.org/10.1016/j.diabet.2022.101331
,2022, 'Cannabinoids for Symptom Management in Patients with Kidney Failure A Narrative Review', Clinical Journal of the American Society of Nephrology, 17, pp. 911 - 921, http://dx.doi.org/10.2215/CJN.11560821
,2022, 'Trimming the fat: Is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review', Clinical Kidney Journal, 15, pp. 1049 - 1059, http://dx.doi.org/10.1093/ckj/sfab288
,2022, 'Digital health and artificial intelligence in kidney research: A report from the 2020 Kidney Disease Clinical Trialists (KDCT) meeting', Nephrology Dialysis Transplantation, 37, pp. 620 - 627, http://dx.doi.org/10.1093/ndt/gfab320
,2022, 'Retrospective study on the epidemiology of antineutrophil cytoplasmic autoantibodies-associated vasculitis in two Australian health districts', Internal Medicine Journal, 52, pp. 605 - 613, http://dx.doi.org/10.1111/imj.15098
,2022, 'A 28-Year-Old Woman Presenting with a Clinical Flare of Systematic Lupus Erythematosus and Abdominal Pain Due to Rectus Sheath Hematoma', American Journal of Case Reports, 23, http://dx.doi.org/10.12659/AJCR.935472
,2022, 'Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study', Canadian Journal of Kidney Health and Disease, 9, http://dx.doi.org/10.1177/20543581221145068
,2021, 'Chronic Kidney Disease-Associated Pruritus: A Review', Kidney and Blood Pressure Research, 46, pp. 659 - 669, http://dx.doi.org/10.1159/000518391
,2021, 'The risk of acute kidney injury with oral anticoagulants in elderly adults with atrial fibrillation', Clinical Journal of the American Society of Nephrology, 16, pp. 1470 - 1479, http://dx.doi.org/10.2215/CJN.05920421
,2021, 'Effect of hemodiafiltration on the progression of neuropathy with kidney failure: A randomized controlled trial', Clinical Journal of the American Society of Nephrology, 16, pp. 1365 - 1375, http://dx.doi.org/10.2215/CJN.17151120
,2021, 'From proteinuria to fibrosis: An update on pathophysiology and treatment options', Kidney and Blood Pressure Research, 46, pp. 411 - 420, http://dx.doi.org/10.1159/000516911
,2021, 'Canagliflozin Improves Cardiovascular and Renal Outcomes across Broad Geographic Regions: Results from CREDENCE', DIABETES, 70, http://dx.doi.org/10.2337/db21-133-LB
,2021, 'Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex in the CREDENCE Trial', DIABETES, 70, http://dx.doi.org/10.2337/db21-129-LB
,2021, 'The Impact of Canagliflozin on the Risk of Neuropathy Events: Results from the CREDENCE Trial', DIABETES, 70, http://dx.doi.org/10.2337/db21-131-LB
,2021, 'Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis', Kidney International Reports, 6, pp. 1058 - 1065, http://dx.doi.org/10.1016/j.ekir.2021.01.020
,2021, 'Relationship between measured and prescribed dialysate sodium in haemodialysis: A systematic review and meta-Analysis', Nephrology Dialysis Transplantation, 36, pp. 695 - 703, http://dx.doi.org/10.1093/ndt/gfaa287
,2021, 'The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals', Kidney International, 99, pp. 551 - 554, http://dx.doi.org/10.1016/j.kint.2020.10.048
,2020, 'Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial Stunning', Journal of Cardiac Failure, 26, pp. 1028 - 1029, http://dx.doi.org/10.1016/j.cardfail.2020.09.001
,2020, 'No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial', Nephrology, 25, pp. 792 - 800, http://dx.doi.org/10.1111/nep.13737
,